FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:753 February 15, 2007 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Inzucchi, S. E. PubMed Citation

To the Editor: I would like to draw attention to two special situations that were not specifically mentioned in the review of management of hyperglycemia in the hospital setting by Dr. Inzucchi (Nov. 2 issue).¹ One is the effect of renal insufficiency on determination of the starting dose of insulin. Since insulin clearance is decreased in patients with renal insufficiency, reducing the starting dose of insulin is essential to avoid hypoglycemia. The second situation is the case of patients who are receiving glucocorticoids. Through increasing insulin resistance, glucocorticoids cause hyperglycemia mainly in the postprandial state. Therefore, these patients frequently require . . . [Full Text of this Article]

This article has been cited by other articles:

• Klein, R. D., Mahoney, M. J. (2008). LabCorp v. Metabolite Laboratories: The Supreme Court Listens, but Declines to Speak.. J Law Med Ethics 36: 141-149